share_log

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

今日最大的盘前股票交易商:周四10大涨跌股
InvestorPlace ·  2021/09/23 07:36

Good morning, investor! We’re diving back into the stock market again today with a look at the biggest pre-market stock movers for Thursday!

早上好,投资者!我们今天再次回到股市,看看周四最大的盘前涨幅!

Source: Shutterstock

消息来源:Shutterstock

We’ve got loads of stock news to discuss as clinical trials, criminal probes, stock offerings, and more move the market.

我们有大量的股票新闻要讨论,因为临床试验、刑事调查、股票发行等等都在推动市场。

Let’s talk about those pre-market stock movers now!

现在让我们来谈谈那些开盘前的股票推动者吧!

Pre-Market Stock Movers: 10 Top Gainers

盘前股票交易商:10大涨幅最大的股票

  1. Amplitude Healthcare (NASDAQ:AMHC) stock is rocketing more than 79% higher on approval from shareholders for its merger with Jasper Therapeutics.

  2. MEDIROM Healthcare (NASDAQ:MRM) shares are soaring nearly 30% after releasing its Key Performance Indicators for August 2021.

  3. Digital Brands Group (NASDAQ:DBGI) stock is climbing over 20% despite a lack of news this morning.

  4. Datasea (NASDAQ:DTSS) shares are increasing roughly 15% on no clear news this morning.

  5. Xenetic Biosciences (NASDAQ:XBIO) stock is gaining more than 13% following a rally on Wednesday.

  6. Regencell Bioscience (NASDAQ:RGC) shares are rising over 10% in pre-market trading today.

  7. Solid Biosciences (NASDAQ:SLDB) stock is sitting 10% higher as it prepares to provide an update on clinical trial data this morning.

  8. PAVmed (NASDAQ:PAVM) shares are jumping more than 9% after one of its subsidiaries joined the Microsoft for Startups program.

  9. Northern Dynasty Minerals (NYSEAMERICAN:NAK) stock is getting a 9% boost as chatter on social media heats up.

  10. Camber Energy (NYSEAMERICAN:CEI) shares are recovering over 8% after falling on Wednesday.

  1. 振幅医疗(纳斯达克:AMHC)在获得股东批准后,其股价飙升了79%以上贾斯珀治疗公司.

  2. MEDIROM医疗保健(纳斯达克:MRM)在发布了2021年8月的关键业绩指标后,股价飙升了近30%。

  3. 数字品牌集团(纳斯达克:DBGI)股价攀升超过20%,尽管今早缺乏消息。

  4. DATASEA(纳斯达克:DTSS)股价在今天上午没有明确消息的情况下上涨了约15%。

  5. 遗传生物科学(纳斯达克:XBIO)股价在周三反弹后上涨了13%以上。

  6. 脑再生科技(纳斯达克:研资局)股价在今天的盘前交易中上涨了10%以上。

  7. 固体生物科学(纳斯达克:SLDB)股价上涨10%,因为该公司准备在今天上午提供最新的临床试验数据。

  8. PAVmed(纳斯达克:PAVM)在其一家子公司加入微软的创业计划后,其股价跃升了9%以上。

  9. 北朝矿产(NYSEAMERICAN:NAK)随着社交媒体上的讨论升温,股价上涨了9%。

  10. 弧形能源(NYSEAMERICAN:CEI)股价在周三下跌后回升逾8%。

10 Top Losers

十大输家

  1. Eargo (NASDAQ:EAR) stock is plummeting more than 58% following news of a criminal probe and the company withdrawing its guidance for 2021.

  2. Magal Security System (NASDAQ:MAGS) shares are diving over 30% on no obvious news this morning.

  3. Synlogic (NASDAQ:SYBX) stock is falling 10% after announcing pricing for a public stock offering.

  4. Marin Software (NASDAQ:MRIN) shares are taking a more than 8% beating as it pulls back from a strong rally on Wednesday.

  5. Aethlon Medical (NASDAQ:AEMD) stock is dropping almost 8% following a rally yesterday.

  6. Vale (NYSE:VALE) shares are decreasing over 7%

  7. Ensysce Biosciences (NASDAQ:ENSC) stock is slipping more than 6% after revealing dividend prices yesterday boosted the shares.

  8. Nanoviricides (NYSEAMERICAN:NNVC) shares are declining over 6%, which continues negative movement from yesterday.

  9. BioCardia (NASDAQ:BCDA) stock is dipping more than 5% after gaining during trading hours on Wednesday.

  10. Aluminum Corp. of China (NYSE:ACH) shares close out our pre-market stock movers down over 4% following a major rally yesterday.

  1. 厄戈(纳斯达克:耳朵在一项刑事调查和该公司撤回2021年指导的消息传出后,该公司股价暴跌逾58%。

  2. Magal安全系统(纳斯达克:杂志)股价今天上午在没有明显消息的情况下暴跌超过30%。

  3. 语法(纳斯达克:SYBX)宣布公开发行股票定价后,股价下跌10%。

  4. Marin软件(纳斯达克:MRIN)股价从周三的强劲反弹中回落,跌幅超过8%。

  5. 艾斯隆医疗(纳斯达克:AEMD)股票下跌了近8%继昨天的一次反弹之后.

  6. 谷谷纽约证券交易所代码:淡水河谷)股价跌幅超过7%

  7. Ensysce生物科学(纳斯达克:ENSC)股价下跌超过6%,昨日公布的股息价格提振了股价。

  8. 纳米杀菌剂(NYSEAMERICAN:NNVC)股价下跌超过6%,延续了昨日以来的负面走势。

  9. 生物心(纳斯达克:BCDA)股价在周三交易时段上涨后,跌幅超过5%。

  10. 中国铝业股份有限公司纽约证券交易所代码:阿奇)股价在昨天大幅上涨后,收盘前股价下跌超过4%。

On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.

在出版之日,威廉·怀特没有(直接或间接)持有本文所述证券的任何头寸。本文表达的观点是作者的观点,以InvestorPlace.com为准出版指南.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发